Compound | GPCR105 ReceptorKI | H3 Receptor KI |
---|---|---|
nM | ||
Imetit | 2.7 ± 0.6 | 0.3 ± 0.2 |
Histamine | 8.1 ± 3.2 | 5.4 ± 4.4 |
Immepip | 9.0 ± 1.0 | 0.4 ± 0.1 |
Impromidine | 12.3 ± 4.0 | 67 ± 16 |
Clobenpropit | 12.8 ± 3.0 | 0.6 ± 0.2 |
N-Methylhistamine | 23 ± 30 | 0.5 ± 0.4 |
Thioperamide | 27 ± 13 | 25 ± 7.4 |
R-α-methylhistamine | 146 ± 68 | 0.7 ± 0.3 |
Burimamide | 180 ± 40 | 84 ± 20 |
Dimaprit | 377 ± 170 | 825 ± 535 |
Clozapine | 510 ± 110 | >10,000 |
Ranitidine | >10,000 | >10,000 |
Cimetidine | >10,000 | >10,000 |
Cyproheptadine | >10,000 | >10,000 |
4-(3-Piperidin-1-yl-propoxy)-benzonitrile | >10,000 | 25 ± 10 |
Diphenhydramine | >10,000 | >10,000 |
K I values for the GPCR105 receptor were determined by competition binding of 3H-histamine. K Ivalues for the histamine H3 receptor were determined by competition binding of 3H-R-α-methylhistamine.